New data from a school asthma management program, “Building Bridges for Asthma Care,” presented today at the American Thoracic Society 2015 International Conference, show a significant decrease in school absenteeism among children with asthma from inner-city schools who were enrolled in the program. Absences dropped 11.75 percent among children enrolled in Building Bridges, compared to an increase of 8.48 percent in children with asthma not in the program.
“Building Bridges for Asthma Care” is a school-based program designed to empower nurses in participating elementary schools to ensure that asthmatic children are identified and provided care according to the National Institute of Health’s clinical treatment guidelines. The objectives of the program are addressing the risk of health disparities and asthma-related absenteeism, as well as its related impact on academic achievement for inner city students.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7506851-gsk-building-bridges-for-asthma-care/
Companies in every part of the nation sponsor tax-qualified benefit plans to attract and retain high quality employees. The plans are designed to offer employees tax relief as they build up their retirement through 401k plans or to buy medical and dental type benefits. However, according to EisnerAmper's Pension Services Group, tax relief that benefits both the employer and the plan participants is at risk of being lost if plan sponsors fail to follow basic qualification requirements by maintaining effective internal control structures over their plans.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7461932-eisneramper-employee-benefits/
Peeling an orange picked fresh off a backyard tree. Enjoying a refreshing lemonade on a hot summer’s day. Sharing a juicy mandarin with your kids after school. These are some of America’s favorite moments and they’re all at risk because California citrus is facing a major threat from a tiny insect and the devastating disease it can spread.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7452951-bayer-cropscience-california-citrus/
Tornado and high winds are some of the most destructive forces of nature. While tornadoes are frequent in the Great Plains, South, and Midwest, there is no state in the country that isn’t at risk. As the nation’s largest property insurer, State Farm wants to make sure you and your family are prepared for the destructive and potentially deadly force of a tornado.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7452831-state-farm-weather-preparedness/
“Make Listening Safe” – with this slogan, the World Health Organization (WHO) is raising awareness of recreational noise-induced hearing loss on International Ear Care Day (March 3, 2015). The focus of this campaign is on teenagers and young adults who frequently put their hearing at risk through exposure to noise. According to current WHO figures, around 1.1 billion young people worldwide are at risk of hearing loss due to unsafe listening practices.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7459951-hear-the-world-make-listening-safe/
Many women don't realize aging makes heart disease likelier. To combat this problem, teams from Brookdale senior living communities nationwide are fanning out to personally alert women 65 and over to their increased risk and provide resources to fight it. The company hopes to reach 10,000 older women through “10,000 Heart to Hearts,” beginning Feb. 1.
“Cardiac disease kills more women than all cancers combined,” said Brookdale chief medical officer Kevin O'Neil, M.D., F.A.C.P. “On average, women develop heart disease 10 years later than men, with their first heart attack occurring at age 70.”
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7087732-brookdale-senior-living/
New research from Carfax suggests that millions of people may be driving, buying, or selling potentially dangerous cars due to an unfixed recall. The company’s annual research on the issue shows more than 46 million cars nationwide have at least one safety recall that’s never been fixed. In fact, five million of them were bought and sold by potentially unsuspecting consumers in 2014.
One of the most alarming discoveries is that people driving or buying family-oriented vehicles – specifically minivans and SUVs – are most at risk. One in three minivans and one in five SUVs has an unfixed recall, according to Carfax.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7385551-carfax-unfixed-recall-data/
Bees are responsible for one in every three bites of food we eat, but their populations are in decline, threatening the food supply as we know it today. According to a recent survey conducted by Cascadian Farm, more than 60 percent of Americans are unfamiliar with colony loss, the phenomenon characterized by honey bees abandoning their hives, never to return. Beyond honey bees, one-third of America’s native bumble bee species are now at risk of extinction. Today, Cascadian Farm—in partnership with The Xerces Society for Invertebrate Conservation and the University of Minnesota Bee Lab—announced its ‘Bee Friendlier’ program to increase awareness of these critical issues and encourage simple actions to help bees thrive.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7330451-cascadian-farm-bee-friendlier-helps-bees-thrive/
Phenogen Sciences, Inc. today announced the availability of BREVAGenplus, an easy-to-use predictive risk test for the millions of women at risk of developing sporadic, or non-hereditary, breast cancer. The test is an enhancement of the company’s first generation product, BREVAGen®. BREVAGenplus assesses both clinical risk factors and genetic markers known to be associated with sporadic, or non-hereditary, breast cancer to determine a woman’s five-year and lifetime risk of developing the disease. The test is designed to facilitate better informed decisions about breast cancer screening and preventive treatment plans for Caucasian, Hispanic and African-American women, age 35 years or above, who have not had breast cancer, lobular carcinoma in situ (LCIS) or ductal carcinoma in situ (DCIS), and have one or more risk factors for developing breast cancer.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7337351-phenogen-sciences-introduces-brevagenplus-breast-cancer-risk-assessment-test/
He lost her once. Is this their second chance? Transforming Belle Cove Resorts’ image will take Dakota Carson’s company to the next level, but it means working with the man who broke her heart. Years ago, Logan Montague walked away from everything, including the woman he loved. Now he’s back, and won’t risk losing Dakota again. Find out more at http://www.LisaWatson.com African American/Romance
This encryption flaw is one of the largest vulnerability the internet has ever seen. Who is affected? Everyone is at risk. Your important information is at risk. This includes, credit card information, email address, password, etc. Watch this video to find out what you can do to make sure your information is safe and how to keep it safe. http://youtu.be/kcNDIzzBClc
Exact Sciences Corp. (NASDAQ: EXAS) announced today that the U.S. Food and Drug Administration (FDA) has approved Cologuard, the company’s noninvasive, stool DNA colorectal cancer screening test. Cologuard is the first noninvasive screening test for colorectal cancer that analyzes both stool DNA and blood biomarkers and has been proven to find 92 percent of cancers and 69 percent of the most advanced precancerous polyps in average risk patients. Cologuard, which is available through healthcare providers, offers people 50 and older at average risk for colorectal cancer an easy–to–use screening test they can do in the privacy of their own home.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7092251-fda-approve-s-exact-sciences-cologuard-screening-test-colorectal-cancer/
